075586725195  |  Set Home  |  Favorite  |  中文
Case report
Case report
Case3# The CR patient of Primary Mediastinal B-large Cell Lymphoma with spread to the CNS
Date: 2019-10-18

32 year-old woman with relapsed/refractory stage IV PMBCL with mediastinal tumor complicated with brain metastases

Cancer History:

First diagnosis of cancer: 02/2018  Cancer type: PMBCL; stage IV 

First recurrence date: 08/2018   sites: left inferior frontal lobe 35*30mm, left lung

Refractory or persistent disease sites: left inferior frontal lobe, left lung, severe CNS symptoms (headache)

Therapy gone through: Surgery: No

Chemotherapy 5 cycles, R-DA-EPOCH ; radiotherapy: no

Targeted drugs: no  immunotherapy: no  others: no

Clinical Trial Number: NCT03125577; enrolled date: 18/09/2018

Interventions: 4SCART (targeting CD19, CD30, CD22), IV after lymphodepletion with Flu-Cy
Consolidation: 4SCART (targeting PSMA)

CRS Grade: 0-1other side effects: diarrhea, headache, and mild fever around 37.5

Treatment response: CR     Quality of Life: improved

Progression-free interval:  1 year  

Current status: No evidence of disease

Disease images before and after CART (with time)

Link of published paper, youtube, patient’s feedback letter: in preparation

ADD: 深圳市南山区粤兴二道6号虚拟大学园重点实验室平台二层   TEL: 075586725195   Email: gimi_trials@szgimi.org

Copyright © 2016 Shenzhen Genoimmune Medical Institute all rights reserved.